The First Decade with the Swedish Prescribed Drug Register – A Systematic Review of the Output in the Scientific Literature
Top Cited Papers
Open Access
- 24 May 2016
- journal article
- review article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 119 (5) , 464-469
Abstract
The aim of this study was to quantify and characterize the scientific output from the Swedish Prescribed Drug Register (SPDR) the first decade after its establishment. A systematic literature search was performed in Medline, EMBASE and PubMed (2005–2014). Additional publications were identified by personal knowledge, reference lists, contact with active authors and a citation search in Web of Sciences. Publications using SPDR data were included in the analysis and characterized regarding study type, presence of patient‐level record linkage, target population and topic. A total of 719 publications were identified in the literature search and an additional 148 by other strategies. Three hundred and thirty‐eight studies fulfilled the inclusion criteria. The majority were analytic (n = 166; 49.1%) or descriptive (n = 100; 29.5%). The remaining studies focused on validation (n = 20; 5.9%), health economics (n = 16; 4.7%) or miscellaneous (n = 36; 10.7%). The analytic studies investigating effects of drug exposure focused mainly on safety (n = 46) and/or effectiveness (n = 24). The first publications appeared in 2007 (n = 6), and in 2014, 90 articles using SPDR were published. Over the years, linkage with other registers using the personal identity number increased (0–88.9% of the publications). The population was often selected by age (49.7%), condition (45.0%) and/or drug (22.8%) and concerned predominantly psychiatric (29.0%) and cardiovascular (20.4%) diseases. In conclusion, this study illustrates that the establishment of a nationwide individual‐based register on dispensed prescription drugs facilitates an encouraging development of pharmacoepidemiological research, both regarding the number of publications and the scientific level of the analyses.Keywords
This publication has 26 references indexed in Scilit:
- Ethical aspects of registry-based research in the Nordic countriesClinical Epidemiology, 2015
- Sources of European drug consumption data at a country levelInternational Journal of Public Health, 2014
- The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature reviewPharmacoepidemiology and Drug Safety, 2013
- Utilization of health care databases for pharmacoepidemiologyEuropean Journal of Clinical Pharmacology, 2011
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- The Nordic Countries as a Cohort for Pharmacoepidemiological ResearchBasic & Clinical Pharmacology & Toxicology, 2010
- The Swedish personal identity number: possibilities and pitfalls in healthcare and medical researchEuropean Journal of Epidemiology, 2009
- The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiology and Drug Safety, 2006
- A review of uses of health care utilization databases for epidemiologic research on therapeuticsJournal of Clinical Epidemiology, 2005
- National Health Data Registers: a Nordic heritage to public healthScandinavian Journal of Public Health, 2002